Summary: Insulin detemir is a long-acting, neutral, and soluble insulin ... of insulin detemir to NPH insulin in patients with type 1 or type 2 diabetes mellitus. In most trials, patients were ...

New to using injectables to treat type 2 diabetes? Understanding the differences can be quite easy. Let's start off slow. Long-acting insulin typically delivers a steady dose throughout the day ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last ...

and the effect of intermediate and long-acting insulin generally stays around for 12 to 24 hours, depending on the specific type of insulin. These insulins are not generally considered to be an ...

By type of insulin, the long-acting insulin analogs segment accounted for the highest revenue-grossing segment in the global ...

Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

For many patients with type 2 diabetes, having to inject basal ... over a six-month period. Crucially, the long-acting insulin was no worse than Tresiba when it came to rates of hypoglycaemia ...

A combination of long-acting insulin once a day and preprandial ... and usually manifests differently in older adults. The type of insulin regimen is chosen according to fasting and daytime ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a ... to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve ...